Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents
Academic Article
Publication Date:
2019
CRIS type:
1.1 Articolo in rivista
List of contributors:
Tucci, M; Roca, E; Ferrari, L; Pia, L; Dalla Volta, A; Bedussi, F; Buttigliero, C; Vittorio Scagliotti, G; Sigala, S; Berruti, A
Published in: